Phase 3 trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

Ken Herrmann; Oliver Sartor; Daniel Castellano; Johann de Bono; Neal Shore; Kim Chi; Mike Crosby; Josep Piulats; Aude Flechon; Xiao Wei; Hakim Mahammedi; Guilhem Roubaud; Hana Študentová; Samson Ghebremariam; Euloge Kpamegan; Teri Kreisl; Neda Delgoshaie; Katja Lehnhoff; Michael Morris; Karim Fizazi

Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Phase 3 trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

Ken Herrmann, Oliver Sartor, Daniel Castellano, Johann de Bono, Neal Shore, Kim Chi, Mike Crosby, Josep Piulats, Aude Flechon, Xiao Wei, Hakim Mahammedi, Guilhem Roubaud, Hana Študentová, Samson Ghebremariam, Euloge Kpamegan, Teri Kreisl, Neda Delgoshaie, Katja Lehnhoff, Michael Morris and Karim Fizazi

Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241064;

Ken Herrmann

1Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Oliver Sartor

2Mayo Clinic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Castellano

3Hospital Universitario 12 de Octubre, Madrid, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johann de Bono

4The Institute of Cancer Research and The Royal Marsden Hospital, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Neal Shore

5Carolina Urologic Research Center and GenesisCare US, Myrtle Beach, SC, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kim Chi

6BC Cancer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mike Crosby

7Veterans Prostate Cancer Awareness

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Josep Piulats

8Catalan Institute of Oncology, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aude Flechon

9Centre Léon Bérard, Lyon, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiao Wei

10Dana-Farber Cancer Institute, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hakim Mahammedi

11Centre Jean Perrin, Clermont-Ferrand, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guilhem Roubaud

12Institut Bergonié, Bordeaux, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hana Študentová

13Palacký University, Faculty of Medicine and Dentistry and University Hospital, Olomouc, Czech Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samson Ghebremariam

14Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Euloge Kpamegan

14Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Teri Kreisl

14Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Neda Delgoshaie

15Novartis Pharma AG, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katja Lehnhoff

15Novartis Pharma AG, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Morris

16Memorial Sloan Kettering Cancer Center

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Karim Fizazi

17Gustave Roussy Institute, Paris-Saclay University, Villejuif, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue supplement 2

June 1, 2024

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Phase 3 trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Phase 3 trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)